Click image to view original image
Chinese Name: Olivan diphosphate
English Name: oritavancin bisphosphate
CAS No. 192564-14-0
Molecular formula: C86H103Cl3N10O34P2
Molecular weight: 1989.09000
Precise quality: 1986.52000
PSA: 736.12000
LogP: 6.85530
Shenzhen Hualai Biological Technology Co., Ltd. has high quality spot, direct sales from manufacturers, inquiry orders, full return of sample costs.
Orbactiv (orit** ancin, Olivan, IV) injection was approved for the treatment of acute bacterial skin and skin structural infections (ABSSSIs) in chneg patients caused by sensitive Gram-positive bacteria (including methicillin-resistant Staphylococcus aureus, MRSA).
On August 7, 2014, the FDA approved the antibiotic Orbactiv (orit** ancin, Olivan Star, IV) injection for Zhiliao in patients with acute bacterial skin and skin structural infections (ABSSSIs) Cheng caused by sensitive Gram-positive bacteria (including methicillin-resistant Staphylococcus aureus, MRSA). Orbactiv is an antibiotic approved by the FDA for Shou single dose Zhiliao regimen for ABSSSIs zhiliao. The whole Zhiliao regimen was terminated when the patient received only one Orbactiv infusion. The approval of Orbactiv also represents a significant progress in bacterial skin and skin structural infections, zhiliao, which is far beyond current clinical standards. At present, patients often need multiple intravenous infusions of antibiotics, and Orbactiv single-dose Zhiliao regimen will significantly reduce the dose burden of patients. HaoeyouPharmacy is currently available to patients in the United States.
Orbactiv was approved on the basis of data from SOLOI and SOLOI studies, which were randomized, double-blind, multicenter clinical trials assessing a single dose.
Orbactiv (1200 mg, IV) Zhiliao regimen was used in 1987 patients with ABSSSI and a large subgroup (n = 405) with MRSA infection was evaluated. These experiments showed that the non-inferiority of the primary and secondary endpoints of the two injections of Orbactiv (1200 mg, IV) only once and vancomycin (1 g or 15 mg/kg body weight) twice a day for 7-10 days were non-inferiority.
Orbactiv injection is suitable for acute bacterial skin and skin structural infections (ABSSSIs) Cheng patients caused by Gram-positive bacterial susceptible strains, including Staphylococcus aureus (including methicillin-sensitive and methicillin-resistant strains), Streptococcus pyogenes, Streptococcus agalactis, Streptococcus pharyngitis and Enterococcus faecalis (vancomyces only). Susceptible strain.
1. The products are beautifully packaged, strong and safe, and easy to transport over long distances.
2. Timely delivery of goods, good door-to-door service, save worry
3. The product content is high, > 99%, and the experimental effect is remarkable.
4. Provide technical information such as quality inspection list, quality standards and atlas with goods, and have a good attitude towards service improvement.
5. Product quality is stable and reliable, supply is stable, price is fair and affordable, industry competitiveness is strong
6. Product price package delivery, price advantage is obvious, the competitiveness of the general company can not do it.
oritavancin bisphosphate Laboratory high purity powder
oritavancin bisphosphate Laboratory high purity powder
oritavancin bisphosphate Laboratory high purity powder
